Moure-Fernandez, Aida <br/><br/>
Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care.  [electronic resource] 

 -  BMJ open  02 2020 
 - e033567 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-6055 
<br/><br/><label>Standard No.: </label>10.1136/bmjopen-2019-033567  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Administration, Oral<br/>Adrenal Cortex Hormones--economics<br/>Adult<br/>Anti-Inflammatory Agents--economics<br/>Asthma<br/>Cost Savings<br/>Cost-Benefit Analysis<br/>Cough<br/>Drug Costs<br/>Drug Prescriptions--economics<br/>England<br/>Female<br/>General Practice<br/>Humans<br/>Male<br/>Middle Aged<br/>Prednisolone--economics<br/>Primary Health Care--economics<br/>Quality of Life<br/>Quality-Adjusted Life Years<br/>Respiratory Tract Infections--complications<br/>Severity of Illness Index<br/>State Medicine